Acute Myeloid Leukemia
57.9% of elderly acute myeloid leukemia study patients respond to chemotherapy
Published in Blood Weekly, January 27th, 2005
K.L. Bourantas and coauthors wrote, "Acute myeloid leukemia (AML) predominantly affects older adults, a population with a poor prognosis, due to age, comorbidities and forms of disease.
"We present a retrospective study of 45 patients older than 60 years of age, with AML, who were diagnosed and/or treated in our clinic in the year 2001."
The authors noted, "Our study refers to 32 men, 63-80 years of age and 13 women, 62-85 years of age. Fourteen of them were diagnosed as de novo leukemia...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-01-27)
More Articles from Blood Weekly
- Acute Lymphocytic Leukemia
Unrelated cord blood transplantation is an option for children with ALL - Adenovirus
Cidofovir effectively treats adenoviral hemorrhagic cystitis in HSCT patients - Embryonic Stem Cell Research
Cryopreservation technique increases ESC viability and reduces differentiation - Spinal Cord Injury
BMTs provide tissue protection/axon guidance after contusive spinal cord injury - Stem Cell Research
Trabecular bone fragment alternative source of mesenchymal stem cells - Acute Myelogenous Leukemia
Clinical outcome not affected in pediatric AML patients with PTPN11 mutations - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
